Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Quoin Pharmaceuticals, Ltd. (QNRX)

$4.28 -2.06% NASDAQ: QNRX · 15-min delayed
  • KFAR SABA,
  • Public · NASDAQ: QNRX
  • 6 employees
$9.0MMarket cap
$0Revenue · FY2021
-$15.8MNet income
6Employees
QNRXNASDAQ
2021IPO

About Quoin Pharmaceuticals, Ltd.

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2021
$0
Net income
-$15.8M
Total assets
$20.4M
Market cap
$9.0M

Source: SEC EDGAR · updated Jun 7, 2026

Multi-year

Revenue & profit trend

Revenue Net income
FY 2025

Financial statements

Income statement

Net income
-$15.8M

Balance sheet

Total assets
$20.4M
Current assets
$20.0M
Total liabilities
$7.3M
Current liabilities
$5.5M
Shareholders’ equity
$13.1M

Cash flow

Operating cash flow
-$13.5M
Investing cash flow
-$4.3M
Financing cash flow
$18.0M
Net cash flow
$195.4K

Statements via Polygon.io (SEC filings)

NASDAQ: QNRX
$4.28 -2.06%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$3.25 $22.30

52-week range

Market cap
$9.0M
Shares outstanding
2.1M
Open
Day range
Prev close
Volume
IPO date
Oct 28, 2021

Quoin Pharmaceuticals, Ltd. (QNRX) Stock Price

  • Reported a net loss of $15.8M in FY2021.
  • Trading 81% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Quoin Pharmaceuticals, Ltd..

Write a review
Newsroom

News about Quoin Pharmaceuticals, Ltd.

News & sentiment via Polygon.io

FAQ

Quoin Pharmaceuticals, Ltd.: frequently asked questions

Is Quoin Pharmaceuticals, Ltd. an American company?

Quoin Pharmaceuticals, Ltd. is a US-based company, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Is Quoin Pharmaceuticals, Ltd. publicly traded?

Yes — Quoin Pharmaceuticals, Ltd. is a publicly traded company. Its stock trades under the ticker symbol QNRX on the NASDAQ.

What does Quoin Pharmaceuticals, Ltd. do?

Quoin Pharmaceuticals, Ltd. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore

Similar companies

Browse all →